Veterans Day: Psychedelic Medicine, Compass Pathways’ FDA Filing and What’s Next

In today’s Trade To Black podcast presented by Flowhub, Shadd Dales and Anthony Varrell mark Veterans Day with Top Gun Options founder and former Navy fighter pilot Matthew “Whiz” Buckley, who leads the push to bring psychedelic medicine to veterans. Cannabis consultant Gretchen Gailey follows with a frank look at what the industry needs to do next in Washington.

Buckley notes that as many as 22 veterans a day still die by suicide. He asks Americans and Canadians who thank a veteran for their service to follow up with a simple question: “Are you good? Do you need anything?”

The conversation centers on the executive order President Trump signed in April 2026 to speed research and access for psychedelic treatments, with veterans at its heart. The order directed new funding for ibogaine research, expanded Right to Try pathways and fast-tracked FDA review. Buckley calls psychedelics for veterans a rare bipartisan issue in Congress, but he warns that progress at the DEA remains slow.

On psilocybin, Compass Pathways (NASDAQ: CMPS) completed its New Drug Application this week for COMP360 as psychedelic medicine in treatment-resistant depression, backed by two Phase 3 trials and a Phase 2b study in more than 1,000 participants. Usona Institute, a nonprofit, has reportedly completed its own application for major depressive disorder, based on one Phase 3 trial. Compass shares fell sharply on the Usona news, which Buckley calls an overreaction. The DEA has also proposed higher 2027 production quotas, nearly tripling MDMA’s allotment. Buckley points to treatment clinics and healthcare real estate as another way to invest in the space.

Gailey describes a demoralized Washington during the lame-duck session. She puts the odds of the federal hemp ban taking effect December 11 at roughly 50-50 and expects any extension to push the fight into the next Congress. She warns that Democrats may revive the MORE Act, which she believes President Trump would veto. With a narrower Senate, she says, the industry now needs to win over only a handful of Republicans, which makes building champions in Congress essential.

Pointing to her Marijuana Moment op-ed on Massachusetts voters rejecting Question 8 by about 75% to 25%, Gailey says opponents are well funded and organized. She notes that she and Ricky Williams were the only national advocates who campaigned in the state. Her message is that the industry’s divisions help its opponents, and that cannabis and hemp must unite and show up on Capitol Hill rather than counting on election results to do the work.

Gailey and Varrell also disagree sharply over whether adult-use cannabis will ever reach Schedule III, and they put money on it. Tune in to hear who’s betting what.


You might also like

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More